IPIX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 10:12):

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective...

Stats
Today's Volume	61 575.00
Average Volume	578 950
Market Cap	1.03M
EPS	$0 ( 2024-04-12 )
Next earnings date	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.200
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2022-12-30	Ehrlich Leo	Sell	11 307 527	Class B Common Stock
2021-10-10	Harness Jane A.	Buy	500 000	Stock Option
2020-09-11	Harness Jane A.	Buy	58 394	Class A Common Stock
2019-09-01	Harness Jane A.	Buy	58 394	Class A Common Stock
2020-09-11	Harness Jane A.	Sell	21 606	Class A Common Stock

INSIDER POWER
-100.00
Last 91 transactions
Buy: 118 435 245 \| Sell: 65 639 262

Innovation Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Innovation Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-373 000 (0.00 %)
EPS:	$-0.00630

FY	2023
Revenue:	$0
Gross Profit:	$-373 000 (0.00 %)
EPS:	$-0.00630

FY	2022
Revenue:	$18 000.00
Gross Profit:	$-364 000 (-2 022.22 %)
EPS:	$-0.0142

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.0400

Financial Reports:

No articles found.

Innovation

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.